SM
DRNA

Sabby Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Sabby Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
2017
Q2 		$602K Sell
2017
Q1 		$680K Buy
2016
Q4 		$288K Buy
2016
Q3 		$294K Buy
2015
Q1 		– Sell
2014
Q4 		$2.4K Sell
2014
Q3 		$3.31K Buy
2014
Q2 		$3.45M Buy
2014
Q1 		$1.46M Buy